These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3728175)

  • 1. The use and abuse of allopurinol in renal failure, the tumour lysis syndrome and HGPRT deficiency.
    Cameron JS; Simmonds HA; Morris GS
    Adv Exp Med Biol; 1986; 195 Pt A():435-40. PubMed ID: 3728175
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease.
    Kannangara DR; Roberts DM; Furlong TJ; Graham GG; Williams KM; Day RO
    Br J Clin Pharmacol; 2012 May; 73(5):828-9. PubMed ID: 22098112
    [No Abstract]   [Full Text] [Related]  

  • 3. Allopurinol in treatment of patients with gout and chronic renal failure.
    Bowie EA; Simmonds HA; North JD
    N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary xanthine stones in an allopurinol-treated gouty patient with partial deficiency of hypoxanthine-guanine phosphoribosyltransferase.
    Sperling O; Brosh S; Boer P; Liberman UA; De Vries A
    Isr J Med Sci; 1978 Feb; 14(2):288-92. PubMed ID: 649360
    [No Abstract]   [Full Text] [Related]  

  • 5. Allopurinol in renal failure and the tumour lysis syndrome.
    Simmonds HA; Cameron JS; Morris GS; Davies PM
    Clin Chim Acta; 1986 Oct; 160(2):189-95. PubMed ID: 3780009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
    Iakunina IA; Barskova VG; Nasonova VA
    Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal failure in infancy due to over-production of urate.
    Batch JA; Riek RP; Gordon RB; Burke JR; Emmerson BT
    Aust N Z J Med; 1984 Dec; 14(6):852-4. PubMed ID: 6598054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should we treat tophaceous gout in patients with allopurinol hypersensitivity?
    Grahame R; Simmonds HA; McBride MB; Marsh FP
    Adv Exp Med Biol; 1998; 431():19-23. PubMed ID: 9598024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the use of allopurinol in chronic gout: monitoring oxypurinol levels to guide therapy.
    Keith MP; Gilliland WR
    Clin Pharmacol Ther; 2011 Sep; 90(3):363-4. PubMed ID: 21862966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
    Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
    Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel HGPRT 293 A>G point mutation presenting as neonatal acute renal failure.
    Wong H; Feber J; Chakraborty P; Drukker A; Filler G
    Pediatr Nephrol; 2008 Feb; 23(2):317-21. PubMed ID: 17934765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allopurinol-1-riboside formation and HGPRT-deficiency.
    Reiter S; Löffler W; Gröbner W; Zöllner N
    Adv Exp Med Biol; 1986; 195 Pt A():447-51. PubMed ID: 3728177
    [No Abstract]   [Full Text] [Related]  

  • 14. Reverse phase partition HPLC for determination of plasma purines and pyrimidines in subjects with gout and renal failure.
    McBurney A; Gibson T
    Clin Chim Acta; 1980 Mar; 102(1):19-28. PubMed ID: 7389105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopurinol therapy of gout with renal complications.
    Sjöberg KH
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):688-90. PubMed ID: 5958699
    [No Abstract]   [Full Text] [Related]  

  • 16. Partial deficiency of hypoxanthine-guanine phosphoribosyltransferase manifesting as acute renal damage.
    Hikita M; Hosoya T; Ichida K; Okabe H; Saji M; Ohno I; Kuriyama S; Tomonari H; Hayashi F; Onouchi K; Fujimori S; Yamaoka N; Sakuma R
    Intern Med; 1998 Nov; 37(11):945-9. PubMed ID: 9868957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allopurinol treatment of gout with renal insufficiency].
    Delbarre F; Lagrue G; Frugier JC; Aignan M
    Sem Hop; 1967 Feb; 43(10):644-51. PubMed ID: 4292983
    [No Abstract]   [Full Text] [Related]  

  • 19. Gout and the kidney.
    Lancet; 1968 May; 1(7549):961-2. PubMed ID: 4171589
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma oxypurinol as a measure of adherence in clinical trials.
    Stamp LK; Merriman T; Frampton C; Zhang M; Wallace M; Miner JN; Dalbeth N
    Ann Rheum Dis; 2018 Feb; 77(2):313-314. PubMed ID: 28057666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.